Search Results - "Morrow, Nadya M"
-
1
Nobiletin Prevents High-Fat Diet-Induced Dysregulation of Intestinal Lipid Metabolism and Attenuates Postprandial Lipemia
Published in Arteriosclerosis, thrombosis, and vascular biology (01-02-2022)“…Nobiletin is a dietary flavonoid that improves insulin resistance and atherosclerosis in mice with metabolic dysfunction. Dysregulation of intestinal…”
Get full text
Journal Article -
2
The citrus flavonoid nobiletin confers protection from metabolic dysregulation in high-fat-fed mice independent of AMPK[S]
Published in Journal of lipid research (01-03-2020)“…Obesity, dyslipidemia, and insulin resistance, the increasingly common metabolic syndrome, are risk factors for CVD and type 2 diabetes that warrant novel…”
Get full text
Journal Article -
3
Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases
Published in Frontiers in genetics (15-10-2020)“…The global prevalence of metabolic disorders, such as obesity, diabetes and fatty liver disease, is dramatically increasing. Both genetic and environmental…”
Get full text
Journal Article -
4
Distinct Identity of GLP-1R, GLP-2R, and GIPR Expressing Cells and Signaling Circuits Within the Gastrointestinal Tract
Published in Frontiers in cell and developmental biology (29-09-2021)“…Enteroendocrine cells directly integrate signals of nutrient content within the gut lumen with distant hormonal responses and nutrient disposal via the…”
Get full text
Journal Article -
5
Pancreas-derived DPP4 is not essential for glucose homeostasis under metabolic stress
Published in iScience (19-05-2023)“…Mice systemically lacking dipeptidyl peptidase-4 (DPP4) have improved islet health, glucoregulation, and reduced obesity with high-fat diet (HFD) feeding…”
Get full text
Journal Article -
6
Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, modulates glucose production, and when absent influences NAFLD progression
Published in JCI insight (24-01-2023)“…Elevated circulating dipeptidyl peptidase-4 (DPP4) is a biomarker for liver disease, but its involvement in gluconeogenesis and metabolic associated fatty…”
Get full text
Journal Article -
7
Immunomodulation and inflammation: Role of GLP-1R and GIPR expressing cells within the gut
Published in Peptides (New York, N.Y. : 1980) (01-06-2024)“…Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are peptide hormones produced by enteroendocrine cells in the small…”
Get full text
Journal Article -
8
-
9
Open Chromatin State of Dpp4 With Glucocorticoid Treatment—Setting up Shop for Metasteroid Diabetes?
Published in Endocrinology (Philadelphia) (01-01-2022)Get full text
Journal Article -
10
Adaptation to short-term extreme fat consumption alters intestinal lipid handling in male and female mice
Published in Biochimica et biophysica acta. Molecular and cell biology of lipids (01-11-2022)“…The small intestine is a highly adaptable organ serving as both a barrier to the external environment and a conduit for nutrient absorption. Enterocytes…”
Get full text
Journal Article -
11
Knockdown of Δ-5 Fatty Acid Desaturase Is More Than Just a Fad
Published in Arteriosclerosis, thrombosis, and vascular biology (01-01-2018)Get full text
Journal Article -
12
GLP-1 receptor agonist-based therapies and cardiovascular risk: a review of mechanisms
Published in Journal of endocrinology (01-10-2024)“…Cardiovascular outcome trials (CVOTs) in people living with type 2 diabetes mellitus and obesity have confirmed the cardiovascular benefits of glucagon-like…”
Get more information
Journal Article -
13
Nobiletin Corrects Intestinal Lipid Metabolism in Ldlr-/- Mice Fed a High-Fat Diet
Published in Atherosclerosis. Supplements (01-06-2018)Get full text
Journal Article